Literature DB >> 6662

Some formulation factors affecting the tensile strength, disintegration and dissolution of uncoated oxytetracycline tablets.

S Esezobo, N Pilpel.   

Abstract

A study has been made of the effects of gelatin binding agent and moisture content on the tensile strength, disintegration and dissolution times of oxytetracycline tablets. These properties all increase with the gelatin content, and maximum tensile strengths occur when the tablets contain between 2.5 and 4.5% w/w of moisture. The properties of the tablets depend on their packing fraction and in general, the disintegration and dissolution times are minimal when the packing fraction is between 0.77 and 0.82. A connection has been established between the disintegration times of the tablets and the time required for 50% of the drug content to dissolve.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 6662     DOI: 10.1111/j.2042-7158.1976.tb04015.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  4 in total

1.  Effect of moisture content on compression properties of two dextrose-based directly compressible diluents.

Authors:  A J Shukla; J C Price
Journal:  Pharm Res       Date:  1991-03       Impact factor: 4.200

2.  Effect of molecular weight of hydrolyzed gelatin on its binding properties in tablets: a technical note.

Authors:  Suruchi N Kokil; Pradeep R Patil; Kakasaheb R Mahadik; Anant R Paradkar
Journal:  AAPS PharmSciTech       Date:  2004-06-08       Impact factor: 3.246

3.  Studies on spray-dried mixtures of chitosan and hydrolyzed gelatin as tablet binder: a technical note.

Authors:  Suruchi Kokil; Pradeep Patil; Kakasaheb Mahadik; Anant Paradkar
Journal:  AAPS PharmSciTech       Date:  2005-10-22       Impact factor: 3.246

4.  Applicability and comparative evaluation of wet granulation and direct compression technology to Rauwolfia serpentina root powder: a technical note.

Authors:  Ch Niranjan Patra; Hemant Kumar Pandit; Satya Prakash Singh; M Vimala Devi
Journal:  AAPS PharmSciTech       Date:  2008-01-16       Impact factor: 3.246

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.